Chambers and colleagues [47] also showed that engineering CAR-NK cells targeting CD73 not only exhibited improved infiltration and cytotoxicity against CD73+ tumor cells but also significantly reduced adenosine production (~0 μM), lowering it below the baseline levels observed in cancer cells cultured alone. The gene discussed is NT5E; the disease is neoplasm.